{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T16:53:52Z","timestamp":1790268832834,"version":"4.1.0"},"reference-count":46,"publisher":"Elsevier BV","issue":"5-6","license":[{"start":{"date-parts":[[2011,10,1]],"date-time":"2011-10-01T00:00:00Z","timestamp":1317427200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Neuropharmacology"],"published-print":{"date-parts":[[2011,10]]},"DOI":"10.1016\/j.neuropharm.2011.06.029","type":"journal-article","created":{"date-parts":[[2011,7,8]],"date-time":"2011-07-08T23:55:16Z","timestamp":1310169316000},"page":"1001-1015","source":"Crossref","is-referenced-by-count":35,"title":["Modulation of NMDA receptor function by inhibition of d-amino acid oxidase in rodent brain"],"prefix":"10.1016","volume":"61","author":[{"given":"Christine A.","family":"Strick","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cheryl","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liam","family":"Scott","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian","family":"Harvey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mih\u00e1ly","family":"Haj\u00f3s","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefanus J.","family":"Steyn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mary A.","family":"Piotrowski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Larry C.","family":"James","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James T.","family":"Downs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian","family":"Rago","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stacey L.","family":"Becker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ayman","family":"El-Kattan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Youfen","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alan H.","family":"Ganong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"suffix":"III","given":"F. David","family":"Tingley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andres D.","family":"Ramirez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patricia A.","family":"Seymour","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Victor","family":"Guanowsky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark J.","family":"Majchrzak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carol B.","family":"Fox","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher J.","family":"Schmidt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Allen J.","family":"Duplantier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.neuropharm.2011.06.029_bib1","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.euroneuro.2007.06.006","article-title":"In vitro and in\u00a0vivo pharmacological profile of AS057278, a selective d-amino acid oxidase inhibitor with potential anti-psychotic properties","volume":"18","author":"Adage","year":"2008","journal-title":"Eur. Neuropsychopharm."},{"key":"10.1016\/j.neuropharm.2011.06.029_bib2","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1016\/S0165-0173(99)00046-6","article-title":"Serotonin model of schizophrenia: emerging role of glutamate mechanisms","volume":"31","author":"Aghajanian","year":"2000","journal-title":"Brain Res. Rev."},{"key":"10.1016\/j.neuropharm.2011.06.029_bib3","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1038\/ng.171","article-title":"Systematic meta-analyses and field synopsis of genetic association studies in schizophrenia: the SzGene database","volume":"40","author":"Allen","year":"2008","journal-title":"Nat. Genet."},{"key":"10.1016\/j.neuropharm.2011.06.029_bib4","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1016\/j.mcn.2006.05.003","article-title":"Behavioral and biochemical characterization of a mutant mouse strain lacking d-amino acid oxidase activity and its implications for schizophrenia","volume":"32","author":"Almond","year":"2006","journal-title":"Mol. Cell Neuroscience."},{"key":"10.1016\/j.neuropharm.2011.06.029_bib5","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.schres.2006.10.010","article-title":"A\u00a0CSF and postmortem brain study of d-serine metabolic parameters in schizophrenia","volume":"90","author":"Bendikov","year":"2007","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.neuropharm.2011.06.029_bib6","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1038\/mp.2008.47","article-title":"d-amino acid oxidase activity and expression are increased in schizophrenia","volume":"13","author":"Burnet","year":"2008","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.neuropharm.2011.06.029_bib7","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/S0896-6273(02)00586-X","article-title":"Theta oscillations in the hippocampus","volume":"33","author":"Buzs\u00e1ki","year":"2002","journal-title":"Neuron"},{"key":"10.1016\/j.neuropharm.2011.06.029_bib8","doi-asserted-by":"crossref","first-page":"13675","DOI":"10.1073\/pnas.182412499","article-title":"Genetic and physiological data implicating the new human gene G72 and the gene for d-amino acid oxidase in schizophrenia","volume":"99","author":"Chumakov","year":"2002","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.neuropharm.2011.06.029_bib9","doi-asserted-by":"crossref","first-page":"3576","DOI":"10.1021\/jm900128w","article-title":"Discovery, SAR, and pharmacokinetics of a novel 3-hydroxyquinolin-2(1H)-one series of potent d-amino acid oxidase (DAAO) inhibitors","volume":"52","author":"Duplantier","year":"2009","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.neuropharm.2011.06.029_bib10","doi-asserted-by":"crossref","first-page":"3357","DOI":"10.1021\/jm800200u","article-title":"Synthesis and biological evaluation of d-amino acid oxidase inhibitors","volume":"51","author":"Ferraris","year":"2008","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.neuropharm.2011.06.029_bib11","doi-asserted-by":"crossref","first-page":"1754","DOI":"10.1074\/jbc.M405726200","article-title":"Serine racemase modulates intracellular d-serine levels through an \u03b1, \u03b2-elimination activity","volume":"280","author":"Foltyn","year":"2005","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.neuropharm.2011.06.029_bib12","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/j.neuron.2007.01.008","article-title":"Hallucinogens recruit specific cortical 5-HT2A receptor-mediated signaling pathways to affect behavior","volume":"53","author":"Gonzalez-Maeso","year":"2007","journal-title":"Neuron"},{"key":"10.1016\/j.neuropharm.2011.06.029_bib13","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1124\/jpet.107.130070","article-title":"Modulation of hippocampal theta oscillation by histamine H3 receptors","volume":"324","author":"Haj\u00f3s","year":"2008","journal-title":"J.\u00a0Pharmacol. Exp. Ther."},{"key":"10.1016\/j.neuropharm.2011.06.029_bib14","doi-asserted-by":"crossref","first-page":"1578","DOI":"10.1248\/bpb.28.1578","article-title":"Sensitive determination of d-amino acids in mammals and the effect of d-amino acid oxidase activity on their amounts","volume":"28","author":"Hamase","year":"2005","journal-title":"Biol. Pharm. Bull."},{"key":"10.1016\/j.neuropharm.2011.06.029_bib15","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.ejphar.2008.03.031","article-title":"Mice lacking d-amino acid oxidase activity exhibit marked reduction of methamphetamine-induced stereotypy","volume":"586","author":"Hashimoto","year":"2008","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2011.06.029_bib16","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/j.brainres.2004.11.031","article-title":"Mice lacking d-amino acid oxidase activity display marked attenuation of stereotypy and ataxia induced by MK-801","volume":"1033","author":"Hashimoto","year":"2005","journal-title":"Brain Res."},{"key":"10.1016\/j.neuropharm.2011.06.029_bib44","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1016\/j.biopsych.2009.01.002","article-title":"Co-Administration of a D-amino acid oxidase inhibitor potentiates the efficacy of D-serine in attenuating prepulse inhibition deficits after administration of dizocilpine","volume":"65","author":"Hashimoto","year":"2009","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.neuropharm.2011.06.029_bib17","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1016\/j.pnpbp.2005.04.023","article-title":"Reduced d-serine to total serine ratio in the cerebrospinal fluid of drug naive schizophrenic patients","volume":"29","author":"Hashimoto","year":"2005","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.neuropharm.2011.06.029_bib18","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1016\/S0022-3565(25)20667-X","article-title":"Cloning and functional characterization of human heteromeric N-methyl-d-aspartate receptors","volume":"278","author":"Hess","year":"1996","journal-title":"J.\u00a0Pharmacol. Exp. Ther."},{"key":"10.1016\/j.neuropharm.2011.06.029_bib45","doi-asserted-by":"crossref","first-page":"16","DOI":"10.2174\/1874241600902010016","article-title":"Effects of D-amino acid oxidase inhibitor on the extracellular D-alanine levels and the efficacy of D-alanine on dizocilpine-induced prepulse inhibition deficits in mice","volume":"2","author":"Horio","year":"2009","journal-title":"Open Clin. Chem. J"},{"key":"10.1016\/j.neuropharm.2011.06.029_bib19","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/S0920-9964(03)00129-4","article-title":"Comparative effects of glycine and d-cycloserine on persistent negative symptoms in schizophrenia: a retrospective analysis","volume":"66","author":"Huresco-Levy","year":"2004","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.neuropharm.2011.06.029_bib20","doi-asserted-by":"crossref","first-page":"e402","DOI":"10.1371\/journal.pbio.0030402","article-title":"Theta rhythms coordinate hippocampal-prefrontal interactions in a spatial memory task","volume":"3","author":"Jones","year":"2005","journal-title":"PLoS Biol."},{"key":"10.1016\/j.neuropharm.2011.06.029_bib21","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1002\/bdd.325","article-title":"Influence of nonspecific brain and plasma binding on CNS exposure: implications for rational drug discovery","volume":"23","author":"Kalvass","year":"2002","journal-title":"Biopharm. Drug Dispos."},{"key":"10.1016\/j.neuropharm.2011.06.029_bib22","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.brainres.2006.05.082","article-title":"Preliminary evidence for a link between schizophrenia and NMDA-glycine site receptor ligand metabolic enzymes, d-amino acid oxidase (DAAO) and kynurenine aminotransferase-1 (KAT-1)","volume":"1106","author":"Kapoor","year":"2006","journal-title":"Brain Res."},{"key":"10.1016\/j.neuropharm.2011.06.029_bib23","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1093\/genetics\/103.2.277","article-title":"Mouse mutant deficient in d-amino acid oxidase activity","volume":"103","author":"Konno","year":"1983","journal-title":"Genetics"},{"key":"10.1016\/j.neuropharm.2011.06.029_bib24","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1001\/archpsyc.1994.03950030035004","article-title":"Subanesthetic effects of noncompetitive NMDA antagonist, ketamine, in humans. Psychotomimetic, perceptual, cognitive, and neuroendocrine responses","volume":"51","author":"Krystal","year":"1994","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.neuropharm.2011.06.029_bib25","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.schres.2008.02.002","article-title":"Increased brain d-amino acid oxidase (DAAO) activity in schizophrenia","volume":"101","author":"Madeira","year":"2008","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.neuropharm.2011.06.029_bib26","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.neures.2005.05.008","article-title":"Spatial learning and long-term potentiation of mutant mice lacking d-amino-acid oxidase","volume":"53","author":"Maekawa","year":"2005","journal-title":"Neurosci. Res."},{"key":"10.1016\/j.neuropharm.2011.06.029_bib27","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.neulet.2004.01.014","article-title":"High affinity d- and l-serine transporter Asc-1: cloning and dendritic localization in the rat cerebral and cerebellar cortices","volume":"358","author":"Matsuo","year":"2004","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.neuropharm.2011.06.029_bib28","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1016\/S0026-895X(25)09633-6","article-title":"Structural requirements for activation of the glycine coagonist site of N-methyl-d-aspartate receptors expressed in xenopus oocytes","volume":"36","author":"Mcbain","year":"1989","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.neuropharm.2011.06.029_bib29","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1023\/A:1007064504007","article-title":"Immunocytochemical localization of d-amino acid oxidase in rat brain","volume":"28","author":"Moreno","year":"1999","journal-title":"J.\u00a0Neurocytol."},{"key":"10.1016\/j.neuropharm.2011.06.029_bib30","doi-asserted-by":"crossref","first-page":"4926","DOI":"10.1073\/pnas.97.9.4926","article-title":"d-Serine is an endogenous ligand for the glycine site of the N-methyl-d-aspartate receptor","volume":"97","author":"Mothet","year":"2000","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.neuropharm.2011.06.029_bib46","series-title":"Guide for the Care and Use of Laboratory Animals","author":"National Research Council","year":"1996"},{"key":"10.1016\/j.neuropharm.2011.06.029_bib31","series-title":"The Rat Brain in Stereotaxic Coordinates","author":"Paxinos","year":"1986"},{"key":"10.1016\/j.neuropharm.2011.06.029_bib32","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1038\/nature08860","article-title":"Human memory strength is predicted by theta-frequency phase-locking of single neurons","volume":"464","author":"Rutishauser","year":"2010","journal-title":"Nature"},{"key":"10.1016\/j.neuropharm.2011.06.029_bib33","doi-asserted-by":"crossref","first-page":"1604","DOI":"10.1523\/JNEUROSCI.17-05-01604.1997","article-title":"d-serine as a neuromodulator: regional and developmental localizations in rat brain glia resemble NMDA receptors","volume":"17","author":"Schell","year":"1997","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.neuropharm.2011.06.029_bib34","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.schres.2008.06.016","article-title":"Genetic associations with schizophrenia: meta analyses of 12 candidate genes","volume":"104","author":"Shi","year":"2008","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.neuropharm.2011.06.029_bib35","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1111\/j.1460-9568.2005.04560.x","article-title":"Activation of alpha7 acetylcholine receptors augments stimulation-induced hippocampal theta oscillations","volume":"23","author":"Siok","year":"2006","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.neuropharm.2011.06.029_bib36","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1124\/jpet.108.147884","article-title":"The behavioral and neurochemical effects of a novel d-amino acid oxidase inhibitor compound 8 [4H-thieno [3,2-b]pyrrole-5-carboxylic acid] and d-serine","volume":"328","author":"Smith","year":"2009","journal-title":"J.\u00a0Pharmacol. Exp. Ther."},{"key":"10.1016\/j.neuropharm.2011.06.029_bib37","doi-asserted-by":"crossref","first-page":"3386","DOI":"10.1016\/j.bmcl.2008.04.020","article-title":"The discovery of fused pyrrole carboxylic acids as novel, potent d-amino acid oxidase (DAAO) inhibitors","volume":"18","author":"Sparey","year":"2008","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.neuropharm.2011.06.029_bib38","doi-asserted-by":"crossref","first-page":"522","DOI":"10.2174\/138161210790361452","article-title":"Strategies to enhance N-Methyl-d-aspartate receptor-mediated neurotransmission in schizophrenia, a critical review and meta-analysis","volume":"16","author":"Tsai","year":"2010","journal-title":"Curr. Pharm. Design"},{"key":"10.1016\/j.neuropharm.2011.06.029_bib39","doi-asserted-by":"crossref","first-page":"1657","DOI":"10.1111\/j.1460-9568.2007.05769.x","article-title":"d-Amino acid oxidase and serine racemase in human brain: normal distribution and altered expression in schizophrenia","volume":"26","author":"Verrall","year":"2007","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.neuropharm.2011.06.029_bib40","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/0301-0082(82)90005-3","article-title":"Brain stem generation of the hippocampal EEG","volume":"19","author":"Vertes","year":"1982","journal-title":"Prog. Neurobiol."},{"key":"10.1016\/j.neuropharm.2011.06.029_bib41","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1073\/pnas.96.2.721","article-title":"Purification of serine racemase: biosynthesis of the neuromodulator d-serine","volume":"96","author":"Wolosker","year":"1999","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.neuropharm.2011.06.029_bib42","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1007\/BF00972212","article-title":"A\u00a0review of the in\u00a0vitro and in\u00a0vivo neurochemical characterization of the NMDA\/PCP\/glycine\/ion channel receptor macrocomplex","volume":"15","author":"Wood","year":"1990","journal-title":"Neurochem. Res."},{"key":"10.1016\/j.neuropharm.2011.06.029_bib43","doi-asserted-by":"crossref","first-page":"1493","DOI":"10.1016\/j.biopsych.2005.03.018","article-title":"Identification of multiple serine racemase (SRR) mRNA isoforms and genetic analyses of SRR and DAO in schizophrenia and d-serine levels","volume":"57","author":"Yamada","year":"2005","journal-title":"Biol. Psychiatry"}],"container-title":["Neuropharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390811002760?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390811002760?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,3,7]],"date-time":"2025-03-07T00:48:17Z","timestamp":1741308497000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0028390811002760"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,10]]},"references-count":46,"journal-issue":{"issue":"5-6","published-print":{"date-parts":[[2011,10]]}},"alternative-id":["S0028390811002760"],"URL":"https:\/\/doi.org\/10.1016\/j.neuropharm.2011.06.029","relation":{},"ISSN":["0028-3908"],"issn-type":[{"value":"0028-3908","type":"print"}],"subject":[],"published":{"date-parts":[[2011,10]]}}}